CDKN2D and colorectal carcinoma: Furthermore, the proliferative defect seen after downregulation of BOK in human HCT-116 colorectal carcinoma cells is dependent on increased cell cycle arrest, due to the higher levels of the cyclin kinase inhibitors p19INK4d and p21cip1 [18].